Eugenol and Isoeugenol Derivatives Group
These substances were identified for action under the Chemicals Management Plan (CMP). This screening assessment focuses on 2 of the 4 substances referred to collectively as the Eugenol and Isoeugenol Derivatives Group. The substances addressed are phenol, 2-methoxy-4-(2-propenyl)- and rose, Rosa canina, ext., also referred to as eugenol and Rosa canina, extract, respectively.
|Substance Group||CAS RN||Common Name||DSL Name||Public comments on the draft screening assessment||Final Screening Assessment||Conclusion on Section 64 criteria||Follow-up Activities|
|Eugenol and Isoeugenol Derivatives||97-53-0||Eugenol||Phenol, 2-methyoxy-4-(2-propenyl)-||HTML||HTML||Do not meet||None planned at this time|
|Rose, Rosa canina, ext.|
|December 22, 2018||Publication of the final screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 152, No. 51.|
|September 30, 2017||Publication and start of 60-day public comment period on the draft screening assessment. The related Notice was published in the Canada Gazette, Part I: Vol. 151, No. 39.|
Two other substances were identified as being part of the Eugenol and Isoeugenol Group at the outset of the third phase of the CMP. These substances were subsequently determined to be of low concern to both human health and the environment, through other approaches. Conclusions for CAS RNs 120-11-6 and 120-24-1 are provided in the Screening Assessment for Substances Identified as Being of Low Concern using the Ecological Risk Classification of Organic Substances and the Threshold of Toxicological Concern (TTC)-based Approach for Certain Substances.
Report a problem or mistake on this page
- Date modified: